Literature DB >> 12829831

Frequent recovery and broad genotype 2 diversity characterize hepatitis C virus infection in Ghana, West Africa.

Daniel Candotti1, Jillian Temple, Francis Sarkodie, Jean-Pierre Allain.   

Abstract

Hepatitis C virus (HCV) infection is thought to mostly become chronic and rarely resolves. HCV infection was serologically screened in 4,984 samples from Ghanaian blood donors, and 1.3% prevalence was found. At least 53% of confirmed anti-HCV carriers had no detectable viral RNA and were considered to have cleared the virus and recovered from the infection. Confirmation was authenticated by the presence of antibodies specific to at least two viral antigens, mostly NS3 and E2. Reactivity to HCV core antigens was lower in Ghanaian than United Kingdom blood donors. The minority of chronically infected donors carried a viral load significantly lower than an unselected comparative group of United Kingdom blood donors (2.5 x 10(5) versus 2.9 x 10(6) IU/ml; P = 0.004). HCV genotype 2 was largely predominant (87%). Sequence clustering was similarly broad in the E1/E2 and NS5 regions. The phylogenetic diversity and the incapacity to distinguish subtypes within genotype 2 in our and others' West African strains suggested that West Africa may be the origin of HCV genotype 2. The genetic diversity extended to the identification of strains clearly separated from known subtypes of genotype 2 and genotype 1. One strain appears to be part of a new HCV genotype. HCV infection in Ghana is characterized by a high rate of recovery and the predominance of broadly divergent genotype 2 strains.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12829831      PMCID: PMC161936          DOI: 10.1128/jvi.77.14.7914-7923.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

1.  Prevalence of hepatitis C virus antibodies and genotypes in asymptomatic, first-time blood donors in Namibia.

Authors:  E Vardas; F Sitas; K Seidel; A Casteling; J Sim
Journal:  Bull World Health Organ       Date:  1999       Impact factor: 9.408

2.  Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C.

Authors:  A Takaki; M Wiese; G Maertens; E Depla; U Seifert; A Liebetrau; J L Miller; M P Manns; B Rehermann
Journal:  Nat Med       Date:  2000-05       Impact factor: 53.440

3.  The natural history of hepatitis C virus infection: host, viral, and environmental factors.

Authors:  D L Thomas; J Astemborski; R M Rai; F A Anania; M Schaeffer; N Galai; K Nolt; K E Nelson; S A Strathdee; L Johnson; O Laeyendecker; J Boitnott; L E Wilson; D Vlahov
Journal:  JAMA       Date:  2000-07-26       Impact factor: 56.272

4.  Seroprevalence of hepatitis B and C, and human immunodeficiency type 1 viruses in a rural population from the Republic of Equatorial Guinea.

Authors:  M Basaras; A Santamaría; M Sarsa; E Gutiérrez; Y de Olano; R Cisterna
Journal:  Trans R Soc Trop Med Hyg       Date:  1999 May-Jun       Impact factor: 2.184

5.  Frequency of hepatitis C virus antibodies and elevated serum alanine transaminase levels in Ghanaian blood donors.

Authors:  J K Acquaye; D Tettey-Donkor
Journal:  West Afr J Med       Date:  2000 Oct-Dec

6.  Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium.

Authors: 
Journal:  J Viral Hepat       Date:  1999-01       Impact factor: 3.728

Review 7.  Natural history of acute hepatitis C.

Authors:  E Tanaka; K Kiyosawa
Journal:  J Gastroenterol Hepatol       Date:  2000-05       Impact factor: 4.029

Review 8.  Clinical significance of hepatitis C virus genotypes.

Authors:  N N Zein
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

9.  Seroprevalence of hepatitis C virus in the general population of northwest Tanzania.

Authors:  B H Tess; A Levin; G Brubaker; J Shao; J E Drummond; H J Alter; T R O'Brien
Journal:  Am J Trop Med Hyg       Date:  2000-01       Impact factor: 2.345

10.  The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies.

Authors:  P Farci; A Shimoda; A Coiana; G Diaz; G Peddis; J C Melpolder; A Strazzera; D Y Chien; S J Munoz; A Balestrieri; R H Purcell; H J Alter
Journal:  Science       Date:  2000-04-14       Impact factor: 47.728

View more
  41 in total

1.  Detection of severe acute respiratory syndrome coronavirus in blood of infected patients.

Authors:  Lisa F P Ng; Michelle Wong; Susie Koh; Eng-Eong Ooi; King-Fai Tang; Hoe-Nam Leong; Ai-Ee Ling; Lora V Agathe; Jenny Tan; Edison T Liu; Ee-Chee Ren; Lee-Ching Ng; Martin L Hibberd
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

2.  Hepatitis C virus prevalence and clearance among US blood donors, 2006-2007: associations with birth cohort, multiple pregnancies, and body mass index.

Authors:  Edward L Murphy; Junyong Fang; Yongling Tu; Ritchard Cable; Christopher D Hillyer; Ronald Sacher; Darrell Triulzi; Jerome L Gottschall; Michael P Busch
Journal:  J Infect Dis       Date:  2010-08-15       Impact factor: 5.226

3.  Impact of host responses on control of hepatitis C virus infection in Chinese blood donors.

Authors:  Tingting Li; Zixuan Chen; Jinfeng Zeng; Jingang Zhang; Wenjing Wang; Ling Zhang; Xin Zheng; Lifang Shuai; Paul Klenerman; Jean-Pierre Allain; Chengyao Li
Journal:  Biochem Biophys Res Commun       Date:  2011-10-29       Impact factor: 3.575

4.  Identification of a naturally occurring recombinant genotype 2/6 hepatitis C virus.

Authors:  Suwanna Noppornpanth; Truong Xuan Lien; Yong Poovorawan; Saskia L Smits; Albert D M E Osterhaus; Bart L Haagmans
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

Review 5.  Injecting drug use: A vector for the introduction of new hepatitis C virus genotypes.

Authors:  Simona Ruta; Costin Cernescu
Journal:  World J Gastroenterol       Date:  2015-10-14       Impact factor: 5.742

6.  Simultaneous visual detection of multiple viral amplicons by dipstick assay.

Authors:  Magda Anastassova Dineva; Daniel Candotti; Fiona Fletcher-Brown; Jean-Pierre Allain; Helen Lee
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

7.  Genotype distribution and molecular epidemiology of hepatitis C virus in blood donors from southeast France.

Authors:  Jean-François Cantaloube; Pierre Gallian; Houssam Attoui; Philippe Biagini; Philippe De Micco; Xavier de Lamballerie
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

8.  HCV genotype distribution and possible transmission risks in Lahore, Pakistan.

Authors:  Waqar Ahmad; Bushra Ijaz; Fouzia-Tahir Javed; Shah Jahan; Imran Shahid; Fawad-Mumtaz Khan; Sajida Hassan
Journal:  World J Gastroenterol       Date:  2010-09-14       Impact factor: 5.742

9.  Cellular immune responses associated with occult hepatitis C virus infection of the liver.

Authors:  Juan A Quiroga; Silvia Llorente; Inmaculada Castillo; Elena Rodríguez-Iñigo; Margarita Pardo; Vicente Carreño
Journal:  J Virol       Date:  2006-11       Impact factor: 5.103

Review 10.  Sequence diversity of hepatitis C virus: implications for immune control and therapy.

Authors:  Joerg Timm; Michael Roggendorf
Journal:  World J Gastroenterol       Date:  2007-09-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.